Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Convertible Debt (2016 - 2017)

Forte Biosciences (FBRX) has disclosed Convertible Debt for 2 consecutive years, with $11.0 million as the latest value for Q1 2017.

  • On a quarterly basis, Convertible Debt changed N/A to $11.0 million in Q1 2017 year-over-year; TTM through Mar 2017 was $11.0 million, a N/A change, with the full-year FY2016 number at $3.4 million, changed N/A from a year prior.
  • Convertible Debt was $11.0 million for Q1 2017 at Forte Biosciences, up from $3.4 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $11.0 million in Q1 2017 to a low of $3.4 million in Q4 2016.